The Efficacy of Endovascular Treatment for Deep Vein Thrombosis.
10.5090/kjtcs.2010.43.3.266
- Author:
Seon Hee KIM
1
;
Sung Woon CHUNG
;
Chang Won KIM
Author Information
1. Department of Thoracic and Cardiovascular Surgery, School of Medicine, Pusan National University, Korea. chungsungwoon@hanmail.net
- Publication Type:Original Article
- Keywords:
Thrombosis;
Deep vein thrombosis;
Endovascular techniques
- MeSH:
Aspirin;
Endovascular Procedures;
Female;
Follow-Up Studies;
Hemorrhage;
Heparin;
Humans;
Incidence;
Pulmonary Embolism;
Recurrence;
Retrospective Studies;
Stents;
Thrombectomy;
Thrombosis;
Venous Insufficiency;
Venous Thrombosis;
Warfarin
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2010;43(3):266-272
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Deep vein thrombosis (DVT) is a serious disease that causes life-threatening pulmonary embolism and chronic venous insufficiency. Anticoagulation is the standard therapy for DVT. However, the results of standard anticoagulation for treating DVT have been disappointing, so endovascular treatment is commonly performed nowadays. The aim of this study was to evaluate the efficacy of an endovascular procedure for treating patients with DVT. MATERIAL AND METHOD: We retrospectively evaluated the clinical data of 29 DVT patients who underwent an endovascular procedure between December 2006 and July 2008. We compared the results of the 29 patients with the results of another 45 patients who were treated with only aspirin and heparin. RESULT: The patient's mean age was 55.4 years in the intervention group and 53.7 years in the control group. DVT occurred more frequently in the females. Catheter-directed thrombolysis was performed in 22 patients (75.8%). Aspiration thrombectomy was performed in 18 patients (62%) and a endovascular stent was placed in 25 patients (86.2%). Fifteen patients (51.7%) underwent percutaneous insertion of a retrievable IVC filter for the prevention of pulmonary embolism. In the control group, thirty nine patients (86.7%) were treated with low-molecular heparin, and seven patients (15.6%) who were contraindicated for warfarin were treated with aspirin. No bleeding complications occurred during thrombolysis or anticoagulation. We analyzed the statistical data according to recurrence of DVT and the incidence of post-thrombotic syndrome (PTS) during the follow-up period. The intervention group had a significantly lower incidence of PTS (p-value=0.008), but they had the same result as the control group for the recurrence of DVT. In addition, death from the DVT did not occur in the intervention group. Thus, we obtained better clinical outcomes in the intervention group as compared to those in the anticoagulation only group. CONCLUSION: Endovascular procedures are effective alternative modalities, as compared to systemic anticoagulation, for the treatment of DVT. But more studies are needed to determine the specific indications and to validate the long-term efficacy of endovascular procedures for the treatment of DVT.
